Cara Therapeutics Stock (NASDAQ: CARA) stock price, news, charts, stock research, profile.
You can purchase shares of Cara Therapeutics (NASDAQ:CARA) through any online brokerage.
Other companies in Cara Therapeutics’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), Gelteq (NASDAQ:GELS), Cocrystal Pharma (NASDAQ:COCP) and Kiora Pharmaceuticals (NASDAQ:KPRX).
Cara Therapeutics has a consensus price target of $12.57.
The stock price for Cara Therapeutics (NASDAQ: CARA) is $0.328 last updated November 12, 2024 at 6:54 PM EST.
There are no upcoming dividends for Cara Therapeutics.
Cara Therapeutics’s Q3 earnings are confirmed for Tuesday, November 26, 2024.
There is no upcoming split for Cara Therapeutics.
Cara Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.